Difference between revisions of "Zhou B, et al. J. Clin. Invest. (2014) cited as Ref 334 in DOI: 10.1038/s41392-020-0110-5 (Q9597)"
Jump to navigation
Jump to search
(Created claim: title (P93): Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 553-563, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 553-563 | ||
| Property / Page(s): 553-563 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:38, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zhou B, et al. J. Clin. Invest. (2014) cited as Ref 334 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zhou B
0 references
2014
0 references
J. Clin. Invest.
0 references
124
0 references
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal (English)
0 references
553-563
0 references
